Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
NCT07423650

Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy

Led by Iuliu Hatieganu University of Medicine and Pharmacy · Updated on 2026-03-24

93

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to determine whether continuous nefopam administration, as part of a multimodal analgesia strategy, reduces opioid consumption and improves patient satisfaction after pancreatoduodenectomy. The main questions are: Does nefopam administration reduce opioid consumption after pancreatoduodenectomy? Does nefopam administration reduce postoperative pain levels after pancreatoduodenectomy? Researchers will compare two other analgesic strategies, namely continuous lidocaine infusion and epidural analgesia, to assess whether they lead to better outcomes. Participants will complete the QoR-15 questionnaire and report their pain levels at predefined time points before and after surgery.

CONDITIONS

Official Title

Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients scheduled for elective pancreatoduodenectomy surgery
  • Agreed to participate in the study
Not Eligible

You will not qualify if you...

  • Refusal to participate
  • Emergency surgery
  • Neurological, muscular, or psychiatric disorders that impair communication
  • Known allergic reactions to the medications used
  • Known hyperalgesia
  • Chronic opioid use
  • Need for reintervention within 48 hours postoperatively
  • Patients with pancreaticogastrostomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Prof. O. Fodor Regional Institute of Gastroenterology and Hepatology

Cluj-Napoca, Cluj, Romania

Actively Recruiting

Loading map...

Research Team

A

Andrei O Mitre

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here